five yeras journey fighting hairloss
    8/8/2026

    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Minoxidil (topical) 5% 2x daily until October 2021
    💊 Finasteride (oral) 1mg daily since October 2021
    💊 Dutasteride (oral) 0.5mg 2x weekly recently started
    💧 Dermarolling (topical) 1mm 1x weekly until recently
    the tone is 😞 negative with some growth results.

    Other terms

    The user has been battling hair loss for five years using Minoxidil, Finasteride, and Dutasteride. Despite some improvements, hair loss persists, and they are considering dietary changes and other treatments for seborrheic dermatitis and hyperhidrosis.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Topical min and dermarolling with seborrheic dermatitis

       4 upvotes 5 months ago
      The user is managing hair loss with oral finasteride, recently switching to dutasteride, and topical minoxidil, but faces challenges due to seborrheic dermatitis. They seek advice on effective regrowth methods that don't worsen their condition, with suggestions including various shampoos like Vichy Dercos and ketoconazole.

      community 15 months of oral Finasteride + Minoxidil

       15 upvotes 9 months ago
      The user has been using 3mg oral Minoxidil and 1.1mg oral Finasteride for 15 months and plans to switch to 5mg oral Minoxidil, 1.1mg oral Finasteride, and 0.1mg oral Dutasteride. They have also used ketoconazole and salicylic acid shampoo for seborrheic dermatitis and hope to see more hair growth with the increased dosage.

    Related Research

    6 / 6 results
      Common Dermatologic Conditions

      research Common Dermatologic Conditions

      14 citations , April 2014 in “Medical Clinics of North America”
      This review discusses common skin conditions in primary care settings and provides guidance on differential diagnoses and selecting appropriate topical treatments, but it reports no new clinical results.
      Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment

      research Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment

      1 citations , July 2023 in “Journal of Clinical Medicine”
      This review provides a detailed overview of the causes, prevalence, pathophysiology, clinical presentation, and treatment of beard alopecia, highlighting conditions such as alopecia areata, pseudofolliculitis barbae, and tinea barbae, and aims to serve as a resource for clinicians handling such cases.

      research Oral Presentations

      July 2012 in “International Journal of Trichology”
      This article discusses various aspects of hair and scalp health, ancient philosophical perspectives on hair, and causes of hair disorders in children, without reporting new clinical results.
      Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia

      research Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia

      June 2026 in “MedScien”
      This study systematically reviewed androgenetic alopecia's clinical features, mechanisms, and treatments, highlighting that current drugs have limitations but emerging therapies and personalized treatment strategies could enhance efficacy and outcomes.
      Phytochemicals as Emerging Therapeutic Agents for Alopecia Treatment

      research Phytochemicals as emerging therapeutic agents for alopecia treatment

      January 2020 in “Elsevier eBooks”
      This chapter provides an overview of phytochemicals with properties to combat alopecia and discusses the potential of flavonoids, found in several herbs, as a safer alternative to synthetic hair loss treatments due to their long-term skin compatibility.